By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



10021 Cheviot Drive

Los Angeles  California  90064  U.S.A.
Phone: 310-476-0270 Fax: 310-471-1020



Company News
SIDMAP Collaboration With University of Utah School of Medicine Published in FASEB Journal 4/5/2013 9:48:37 AM
SIDMAP Technology Used to Characterize Novel Drug for Type 2 Diabetes 7/21/2010 9:02:56 AM
SIDMAP Chief Scientist to Collaborate on Cancer Research Grant with Johns Hopkins University School of Medicine 4/6/2010 11:32:28 AM
SIDMAP Enters Japanese Market for Pharmaceutical Research Services with Two New Contracts for Metabolomics Testing and Biomarker Development 4/7/2009 9:50:00 AM
SIDMAP Launches a Metabolomics Service for Early Detection of Drug-Induced Liver and Kidney Toxicity. 10/13/2008 9:04:14 AM
SIDMAP Collaboration Leads to Discovery of Novel Biomarker for Early Detection the Metabolic Syndrome 6/12/2007 2:06:26 PM
SIDMAP: Discovery of Early Metabolic Marker for Drug Toxicity on the Liver to Be Announced at Metabolic Society's 3rd Annual Conference in Manchester, U.K., June 11-14, 2007 6/7/2007 2:10:24 PM
SIDMAP Hires Fred Siegman, Ph.D. As New Vice President Of Sales And Marketing10/19/2005 5:12:38 PM
SIDMAP Launches New Technology To Accelerate The Drug Development And Testing Process10/19/2005 5:10:26 PM
SIDMAP Opens New Laboratory10/19/2005 5:09:32 PM